Study Links Long COVID to Persistent SARS-CoV-2; Urges Antiviral Trials and Drug Development

November 29, 2024
Study Links Long COVID to Persistent SARS-CoV-2; Urges Antiviral Trials and Drug Development
  • Understanding the distinction between live virus and viral fragments is essential, as only live viruses can be effectively targeted by antiviral treatments.

  • Research suggests that some individuals may harbor live virus rather than just inactive viral remnants, which is critical for the development of targeted treatments.

  • Long COVID can affect individuals across all age groups, but it has the most significant impact on those aged 30 to 49 years.

  • They emphasize the urgency of conducting trials on known antiviral treatments and the need for new drug development to effectively address the challenges posed by long COVID.

  • Recent research indicates that long COVID may be linked to the persistent presence of the SARS-CoV-2 virus in the body, a concept referred to as 'viral persistence.'

  • Evidence of viral RNA has been found in various tissues and blood samples one to four months after acute infection, which correlates with an increased risk of developing long COVID.

  • Some studies have detected replicating viral RNA and proteins in patients' blood years after their initial infection, suggesting ongoing viral activity in hidden reservoirs within the body.

  • In light of these findings, there is a pressing call for expedited clinical trials of antiviral therapies to treat long COVID, including the potential repurposing of existing medications like metformin.

  • The authors of recent studies advocate for increased government support and further research to develop new drugs and clinical trial platforms specifically targeting long COVID.

  • Raising public awareness about long COVID, its associated risks, and prevention strategies is vital, especially since multiple infections can increase the risk of developing long COVID.

  • Preventive measures to reduce COVID-19 exposure are recommended, including improving indoor air quality, using high-quality masks, and staying current with vaccinations.

  • Despite accumulating evidence, definitive proof of the long-term presence of live virus remains elusive due to the technical challenges involved in isolating it from bodily reservoirs.

Summary based on 6 sources


Get a daily email with more Science stories

More Stories